Orthopaedic Proceedings
Vol. 96-B, Issue SUPP_11 | Pages 62 - 62
1 Jul 2014
Full Access
Based upon genetic analysis, decorin is an exciting pharmacologic agent of potential anti-fibrogenic effect on arthrofibrosis in our animal model. While the pathophysiology of arthrofibrosis is not fully understood, some anti-fibrotic molecules such as decorin could potentially be used for the prevention or treatment of joint stiffness. The goal of this study was to determine whether intra-articular administration of decorin influences the expression of genes involved in the fibrotic cascade ultimately leading to less contracture in an animal model.Summary
Introduction
Results 1 - 1 of 1
Results per page:
